A randomized, double-blind, placebo-controlled trial of selective digestive decontamination using oral gentamicin and oral polymyxin E for eradication of carbapenem-resistant Klebsiella pneumoniae carriage.
about
Selective decontamination and antibiotic resistance in ICUsAntibacterial Resistance in Patients with Hematopoietic Stem Cell Transplantation.Trends in human fecal carriage of extended-spectrum β-lactamases in the community: toward the globalization of CTX-M.Oral gentamicin gut decontamination for prevention of KPC-producing Klebsiella pneumoniae infections: relevance of concomitant systemic antibiotic therapy.Intestinal decontamination of multidrug-resistant Klebsiella pneumoniae after recurrent infections in an immunocompromised host.Selective decontamination of the digestive tract: an update of the evidence.Carbapenem-resistant Enterobacteriaceae: biology, epidemiology, and management.Intestinal decolonization of Enterobacteriaceae producing extended-spectrum β-lactamases (ESBL): a retrospective observational study in patients at risk for infection and a brief review of the literature.Mechanisms of antimicrobial resistance in Gram-negative bacilli.Hospital Readmissions in Patients With Carbapenem-Resistant Klebsiella pneumoniae.Decolonization in Prevention of Health Care-Associated Infections.Causes, consequences, and perspectives in the variations of intestinal density of colonization of multidrug-resistant enterobacteria.Emergence of colistin resistance in Enterobacteriaceae after the introduction of selective digestive tract decontamination in an intensive care unit.Risk factors and outcomes of carbapenem-resistant Klebsiella pneumoniae infections in liver transplant recipientsLimiting and controlling carbapenem-resistant Klebsiella pneumoniae.Risk of infection following colonization with carbapenem-resistant Enterobactericeae: A systematic review.Antibiotic prophylaxis in the era of multidrug-resistant bacteria.Selective decontamination of the digestive tract: the mechanism of action is control of gut overgrowth.Bloodstream infections caused by carbapenemase-producing Klebsiella pneumoniae: a clinical perspective.Confronting carbapenemase-producing Klebsiella pneumoniae.Carbapenem-Resistant Enterobacteriaceae: Laboratory Detection and Infection Control Practices.Colonization and infection with extended spectrum beta-lactamase producing Enterobacteriaceae in high-risk patients - Review of the literature from a clinical perspective.Multidrug-resistant bacterial infections after liver transplantation: an ever-growing challenge.Current and future treatment options for infections caused by multidrug-resistant Gram-negative pathogens.Critical issues for Klebsiella pneumoniae KPC-carbapenemase producing K. pneumoniae infections: a critical agenda.Fighting antibiotic resistance in the intensive care unit using antibiotics.Population-based incidence of carbapenem-resistant Klebsiella pneumoniae along the continuum of care, Los Angeles County.Infectious Considerations in the Pre-Transplant Evaluation of Cirrhotic Patients Awaiting Orthotopic Liver Transplantation.Fecal microbiota transplantation for the intestinal decolonization of extensively antimicrobial-resistant opportunistic pathogens: a review.Multidrug-resistant bacteria in hematology patients: emerging threats.Multidrug-resistant organisms in liver transplant: Mitigating risk and managing infections.Natural history and decolonization strategies for ESBL/carbapenem-resistant Enterobacteriaceae carriage: systematic review and meta-analysis.Colonization of liver transplant recipients with KPC-producing Klebsiella pneumoniae is associated with high infection rates and excess mortality: a case-control analysis.Clinical Pharmacokinetics and Pharmacodynamics of Colistin.Mortality Associated with Bacteremia Due to Colistin-Resistant Klebsiella pneumoniae with High-Level Meropenem Resistance: Importance of Combination Therapy without Colistin and Carbapenems.A randomized clinical trial on the effectiveness of a symbiotic product to decolonize patients harboring multidrug-resistant Gram-negative bacilli.Oral decontamination with aminoglycosides is associated with lower risk of mortality and infections in high-risk patients colonized with colistin-resistant, KPC-producing Klebsiella pneumoniae.Carbapenem-resistant Enterobacteriaceae in special populations: Solid organ transplant recipients, stem cell transplant recipients, and patients with hematologic malignancies.The evolving threat of carbapenem-resistant infections after liver transplantation: The case of Acinetobacter baumannii.Considerations About Antimicrobial Stewardship in Settings with Epidemic Extended-Spectrum β-Lactamase-Producing or Carbapenem-Resistant Enterobacteriaceae.
P2860
Q21146640-6B4D3676-A05F-4DCC-81D5-F07BB85977E4Q30238945-53A38143-A5A2-4CB2-8676-BB59F860C6CDQ30354148-AE9E0FB4-57A5-415E-8EE4-4390894C0302Q33622988-0574DE5C-22AF-49AB-BC43-60ECFC25D95FQ34173608-A2D7C366-C778-4D39-A6DA-515EFB54B0DCQ34329740-1E13FFF4-0CD2-4CC8-9663-35C12A4F8DC2Q34437229-9A27EDF3-28A9-422A-A73D-D4C60D9653EAQ35825390-2DEDC888-FC06-4895-B85B-27ED5A3F0D6FQ35935319-0AC8BE15-61ED-48E6-893D-A8946A91E8D8Q36672253-4A427FB8-5CC6-4D7F-BC1D-28EEBFABF235Q36675240-B95DEAC9-E8F5-4142-8617-D000DF8B8CE3Q36878269-92740F22-59B5-4929-8661-845F6092FA5AQ36969991-E8CBDC10-FF27-4437-A309-C5288C7D78B7Q36977262-195BEEF5-ED0C-455B-95EF-F86CA1570A3CQ37391003-C58F7715-23FC-4281-8117-452A370666CCQ37603930-B5FFB064-F70B-4F37-9BDB-427791D7E158Q38005208-F5149270-A904-4E1C-B27B-B969EADC695EQ38045790-84D7C52D-221E-4A23-9C0C-7F71B9699F16Q38068604-97D02C50-932A-4B23-AEDC-01E13CF83D05Q38135903-EF81FA9E-F7C4-4FC2-A7C6-D2405CEF7C8FQ38152302-AA69DFB9-774E-4729-94A0-C8BA78D30902Q38185120-FE29725E-9A7D-44BF-B18E-B44A7AE4B5AFQ38216011-C585C002-9FEF-4A7C-A664-FC8AA1555EBCQ38262205-7EB0C92C-2F97-4E4B-B106-D2A16C69E153Q38358638-93E7A7CA-0CCB-4BB1-909E-F630F28510EAQ38392073-87453300-B9C8-4B3F-9FCE-C690CA56F11BQ38428213-708F0340-533F-498A-91B8-DF0E06F9C521Q38689820-8DB981D9-4B88-4D7A-BE6E-E21511B7B104Q38838013-2DAF7382-F884-40C4-8979-B63718C60108Q38838498-DF233074-84BC-4F84-95BE-D61F00650FF0Q38845084-C0843132-CF7A-4CD4-9D82-7EEAD0E596FEQ38868953-6CBF69B7-C43F-4C7A-837F-E59B164E6B27Q39197456-5A914782-12D1-4D5B-A74A-8DF383311866Q39333751-66B6DA3D-16E5-449B-A4D3-8BFDD436C4C4Q40192475-65FCBA31-30A4-4EF4-85B1-FA0474D06F90Q40464218-70D440C8-A903-4068-913B-2971CA60E6E7Q40587105-9CC25821-FB66-4DD8-BF82-4BDC9B57BBC6Q40595790-914A306B-D901-4DE7-BF94-CD1A1FAE866FQ40770455-471A2906-E28B-42DD-83F4-0083F5A97EB6Q41004466-32BD0F85-CA9C-4BC3-AA8D-3440F47D5F0E
P2860
A randomized, double-blind, placebo-controlled trial of selective digestive decontamination using oral gentamicin and oral polymyxin E for eradication of carbapenem-resistant Klebsiella pneumoniae carriage.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh-hant
name
A randomized, double-blind, pl ...... lebsiella pneumoniae carriage.
@en
A randomized, double-blind, pl ...... lebsiella pneumoniae carriage.
@nl
type
label
A randomized, double-blind, pl ...... lebsiella pneumoniae carriage.
@en
A randomized, double-blind, pl ...... lebsiella pneumoniae carriage.
@nl
prefLabel
A randomized, double-blind, pl ...... lebsiella pneumoniae carriage.
@en
A randomized, double-blind, pl ...... lebsiella pneumoniae carriage.
@nl
P2093
P2860
P921
P356
P1476
A randomized, double-blind, pl ...... Klebsiella pneumoniae carriage
@en
P2093
Abraham Borer
Baha Yousef
Francisc Schlaeffer
Hana Polachek
Klaris Riesenberg
Nehama Peled
Rozalia Smolykov
Seada Eskira
Shlomi Codish
Yafa Trabelsi
P2860
P356
10.1086/663206
P577
2011-11-30T00:00:00Z